|
|
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
Julien Edeline
,
Laurence Crouzet
,
Boris Campillo-Gimenez
,
Yan Rolland
,
Marc Pracht
et al.
Journal articles
hal-01217979v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Occupational radiation exposure of medical staff performing (90)Y-loaded microsphere radioembolization
Sophie Laffont
,
Yan Rolland
,
Valérie Ardisson
,
Julien Edeline
,
Marc Pracht
et al.
Journal articles
hal-01255872v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
In Vitro Demonstration of Synergy/Additivity Between 188Rhenium and Sorafenib on Hepatoma Lines: Preliminary Results
Marc Pracht
,
Julien Edeline
,
Nicolas Lepareur
,
Laurence Lenoir
,
Valérie Ardisson
et al.
Anticancer Research, 2013, 33 (9), pp.3871-3877
Journal articles
hal-00934873v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study
Juliette Viaud
,
Clémence Brac
,
Pascal Artru
,
Estelle Le Pabic
,
Bérengère Leconte
et al.
Journal articles
hal-01534249v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
Laurent Sulpice
,
Michel Rayar
,
Bruno Turlin
,
Eveline Boucher
,
Pascale Bellaud
et al.
Journal articles
hal-01069630v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatocellular carcinoma in elderly patients: challenges and solutions
Angélique Brunot
,
Samuel Le Sourd
,
Marc Pracht
,
Julien Edeline
Journal articles
hal-01470714v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns
Alexandra Frelau
,
Marc Pracht
,
Samuel Le Sourd
,
Alexandra Lespagnol
,
Romain Corre
et al.
Journal articles
hal-01815717v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.
Julien Edeline
,
Cédric Coulouarn
,
Laurence Crouzet
,
Marc Pracht
,
Nicolas Lepareur
et al.
Journal articles
hal-01237102v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|